El Salvador vs Qatar: The number of people with susceptibility test result for rifampicin
El Salvador
316
in 2021
Qatar
411
in 2021
El Salvador rank
87th
Qatar rank
84th
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Qatar
How they compare
Qatar currently reports 411 against 316 in El Salvador, a difference of 95.
That makes Qatar's figure about 1.3 times El Salvador's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was El Salvador ahead.
El Salvador ranks 87th and Qatar ranks 84th of 155 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 844.33 | 297.67 | 546.67 | El Salvador |
| 2020s | 418.5 | 392.5 | 26 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Qatar?
- Qatar, at 411 against 316 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Qatar?
- 95, with Qatar ahead.
- How many years of comparable data are there for El Salvador and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 87th and Qatar ranks 84th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.